What is Parkinson's Phase 3 Study CoQ10 QE3?

Category: Others

false

See also: Clinical Trial

NCT00740714 is a a clinical trial of the effects of Coenzyme Q10 with vitamin E in Parkinson Disease. Other study IDs includes: U01NS050324, QE3.

Reported purpose & perceived effectiveness

Purpose
Patients
Patients with evaluations
Perceived effectiveness
Patients
Patients with evaluations

  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 0
Moderate 0
Mild 0
None 1

Commonly reported side effects and conditions associated with Parkinson's Phase 3 Study CoQ10 QE3

Side effect Patients

Why patients stopped taking Parkinson's Phase 3 Study CoQ10 QE3

Multiple reasons could be selected

Reason Patients
Other 1
See all 1 patient who’ve stopped using Parkinson's Phase 3 Study CoQ10 QE3

Duration

Stopped using Parkinson's Phase 3 Study CoQ10 QE3

Duration Patients
1-2 years 1

Adherence


Always
Patients
0
0%
Usually
Patients
1
100%
Sometimes
Patients
0
0%
Never taken as prescribed
Patients
0
0%

Burden


Very hard to take
Patients
0
0%
Somewhat hard to take
Patients
0
0%
A little hard to take
Patients
0
0%
Not at all hard to take
Patients
1
100%

Cost per month


Cost per month
$200+
Patients
0
0%
Cost per month
$100-199
Patients
0
0%
Cost per month
$50-99
Patients
0
0%
Cost per month
$25-49
Patients
0
0%
Cost per month
< $25
Patients
1
100%
Cost per month
Not specified
Patients
0
0%
Last updated:
There are no evaluations for Parkinson's Phase 3 Study CoQ10 QE3.